newsConnected drug delivery devices market to grow to $4bn by 20282 March 2021 | By Hannah Balfour (European Pharmaceutical Review)A new report reveals the COVID-19 pandemic, prevalence of chronic disease and increasing patient engagement will all drive adoption of connected drug delivery devices.
newsEMA recommends eight drugs for approval from April meeting5 May 2020 | By Victoria Rees (European Pharmaceutical Review)The EMA's human medicines committee has adopted a positive opinion for eight medicines, recommending their marketing authorisation.